A rare collaboration of top pharmaceutical companies, regulators and university researchers has begun attacking one of the toughest problems in medicine: why severe drug side effects strike a small percentage of patients.Click here to access the article.
Thursday, September 27, 2007
International Severe Adverse Events Consortium
From the Boston Globe article:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment